financetom
Business
financetom
/
Business
/
Rio Tinto has contingency plans to minimize impact from Canada rail stoppage
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Rio Tinto has contingency plans to minimize impact from Canada rail stoppage
Aug 22, 2024 10:51 PM

TORONTO, Aug 22 (Reuters) - Rio Tinto expects

the labor dispute between the workers and the management of

Canada's two biggest rail networks will affect its ability to

receive raw materials at several sites across Canada and ship

products to customers in North America, the miner told Reuters

on Thursday.

Rio Tinto added that it has contingency plans in place to

minimize impact that includes trucking certain materials and

products and increasing use of its own rail network.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
1911 Gold Receives $1.7 Million from Early Exercise of Warrants
1911 Gold Receives $1.7 Million from Early Exercise of Warrants
Sep 27, 2024
08:59 AM EDT, 09/26/2024 (MT Newswires) -- 1911 Gold ( AUMBF ) said on Thursday that it received nearly $1.7 million from the early exercise of warrants by 2176423 Ontario, a corporation that is beneficially owned by Eric Sprott. 1911 said the funds will help the company finalize plans for its upcoming drill program in mid-October at the Rice Lake...
Acumen, Lonza Extend Deal to Add Manufacturing of Sabirnetug for Alzheimer's Disease
Acumen, Lonza Extend Deal to Add Manufacturing of Sabirnetug for Alzheimer's Disease
Sep 27, 2024
08:58 AM EDT, 09/26/2024 (MT Newswires) -- Acumen Pharmaceuticals ( ABOS ) said Thursday that it has extended its partnership with Lonza to offer drug product manufacturing for clinical and potential commercial supply from the latter's Visp, Switzerland, facility to treat Alzheimer's disease. The extended agreement requires Lonza to produce cGMP drug product of sabirnetug for the current and future...
BRIEF-Gevo Acquires Cultivateai For Its Verity Business Unit
BRIEF-Gevo Acquires Cultivateai For Its Verity Business Unit
Sep 27, 2024
Sept 26 (Reuters) - Gevo Inc ( GEVO ): * GEVO ACQUIRES CULTIVATEAI FOR ITS VERITY BUSINESS UNIT * GEVO INC ( GEVO ) - ACQUIRES CULTIVATEAI FOR $6 MILLION IN CASH Source text for Eikon: Further company coverage: ...
Enanta Pharmaceuticals Says Phase 2a Trial of Potential RSV Treatment Meets Endpoints
Enanta Pharmaceuticals Says Phase 2a Trial of Potential RSV Treatment Meets Endpoints
Sep 27, 2024
08:58 AM EDT, 09/26/2024 (MT Newswires) -- Enanta Pharmaceuticals ( ENTA ) said Thursday that a phase 2a study evaluating EDP-323 in adults with respiratory syncytial virus, or RSV, met its primary and secondary endpoints. Reductions of 85% to 87% in viral load area under the curve, 97% to 98% in infectious viral load AUC, and 66% to 78% in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved